Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC

Clinical trial NCT05310643 · RECRUITING

Trial details

NCT number: NCT05310643
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2022-05-05
Primary completion: 2025-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.